Ariad Pharmaceuticals Chairman Sells 62K Shares and 4 Insider Sales to Note

Berger Harvey J M D who is Chairman & CEO at Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), sold 62,902 shares at $18.51 per share for a total value of $1,164,335. The shares recently traded at $18.11, down $0.4, or 2.16% since the insider sale.

ARIA-20130816

Alexander Susan who is EVP & WW Head of HR at Sotheby’s (NYSE:BID), sold 16,127 shares at $45.63 per share for a total value of $735,877. The shares recently traded at $44.73, down $0.9, or 1.97% since the insider sale.

BID-20130816

Doherty Catherine T. who is SVP, Clinical Franchises at Quest Diagnostics Inc. (NYSE:DGX), sold 33,000 shares at $59.85 per share for a total value of $1,975,126. The shares recently traded at $58.83, down $1.02, or 1.7% since the insider sale.

DGX-20130816

Cannon John who is EVP, GC & Chief PAO at WellPoint Inc. (NYSE:WLP), sold 11,494 shares at $86.50 per share for a total value of $994,231. The shares recently traded at $85.42, down $1.08, or 1.25% since the insider sale.

WLP-20130816

Hagedorn Katherine Littlefield who is Director at The Scotts Miracle-Gro Co. (NYSE:SMG), sold 10,274 shares at $53.96 per share for a total value of $554,383. The shares recently traded at $53.59, down $0.37, or 0.69% since the insider sale.

SMG-20130816

Investing Insights: Where Will United Continental Go Next?

More from The Cheat Sheet